Phase I Dose Escalation Study of Sodium Stibogluconate (SSG), a Protein Tyrosine Phosphatase Inhibitor, Combined With Interferon Alpha for Patients With Solid Tumors
Journal of Cancer - Australia
doi 10.7150/jca.2.81
Full Text
Open PDFAbstract
Available in full text
Categories
Date
January 1, 2011
Authors
Publisher
Ivyspring International Publisher